Breakthrough Long-COVID ‘Brain Fog’ Drug Being Developed by Augusta University Researchers
Retrieved on:
Thursday, December 1, 2022
Giant, COVID-19, Growth, Doctor of Philosophy, TED (conference), CDC, Archives of Oral Biology, Polyphenol, Augusta University, EPA, Prevalence, RNA, EGCG, Long COVID, Biotechnology, Brain, ACE2, Dentistry, Degenerative disease, Amazon, Outsider, Research, Headache, Marketing, Thought, Royal National Institute for Deaf People, NIDCD, Plant, Anosmia, Drug development, CMOS, NIH, Memory, CMO, Fraction, Severe acute respiratory syndrome coronavirus 2, AU, Communication, FDA, Deafness, Pharmaceutical industry, Pharma
Thats why we need one or more Pharma partners to help us cross the proverbial finish line.
Key Points:
- Thats why we need one or more Pharma partners to help us cross the proverbial finish line.
- Green tea polyphenols are natural bioactive compoundsphytochemicalswhich are known for their antiviral, antioxidant, and anti-inflammatory effects.
- Combined with neuroprotective, anti-inflammatory, and antioxidant activities, its logical that it would also yield benefits for Long-COVID relief and prevention.
- For additional information about the companies who trust Chief Outsiders as their premier source for business growth acceleration, click here .